Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids.
about
Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cellsPhysical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementationMolecular genetic analysis of an endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signalingThe Crystal Structure of Human Soluble CD14 Reveals a Bent Solenoid with a Hydrophobic Amino-Terminal PocketThe science of fatty acids and inflammationProduction of the acute-phase protein lipopolysaccharide-binding protein by respiratory type II epithelial cells: implications for local defense to bacterial endotoxinsPortable microfluidic chip for detection of Escherichia coli in produce and bloodThe dual role of lipopolysaccharide as effector and target molecule.Soluble CD14 activates monocytic cells independently of lipopolysaccharideTargeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels.Mechanisms of tissue injury in sepsis: contrasts between gram positive and gram negative infection.Novel therapies for sepsis: antiendotoxin therapies.Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.A novel ML protein from Manduca sexta may function as a key accessory protein for lipopolysaccharide signaling.Soluble CD14 is a nonspecific marker of monocyte activation.Crosstalk between reverse cholesterol transport and innate immunity.Development of a mast cell-based biosensorToll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages.Heterotrimeric G proteins physically associated with the lipopolysaccharide receptor CD14 modulate both in vivo and in vitro responses to lipopolysaccharideAdipocyte lipopolysaccharide binding protein (LBP) is linked to a specific lipidomic signature.Consequences of interaction of a lipophilic endotoxin antagonist with plasma lipoproteinsTLR4/CD14-mediated PI3K activation is an essential component of interferon-dependent VSV resistance in macrophages.Synthesis and surface expression of CD14 by human endothelial cells.Serum amyloid P component prevents high-density lipoprotein-mediated neutralization of lipopolysaccharide.A phosphatidylserine species inhibits a range of TLR- but not IL-1beta-induced inflammatory responses by disruption of membrane microdomains.The differential impact of disulfide bonds and N-linked glycosylation on the stability and function of CD14.Biochemical and functional characterization of membrane blebs purified from Neisseria meningitidis serogroup B.Lipopolysaccharide induces expression of fibronectin alpha 5 beta 1-integrin receptors in human monocytic cells in a protein kinase C-dependent fashion.CD14-dependent clearance of apoptotic cells by human macrophages: the role of phosphatidylserine.Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation.Hepatocytes contribute to soluble CD14 production, and CD14 expression is differentially regulated in hepatocytes and monocytes.CD14-dependent internalization and metabolism of extracellular phosphatidylinositol by monocytes.Phosphatidylinositides bind to plasma membrane CD14 and can prevent monocyte activation by bacterial lipopolysaccharide.Cultured Mesenchymal Stem Cells Stimulate an Immune Response by Providing Immune Cells with Toll-Like Receptor 2 Ligand.Geranylgeranylacetone ameliorates inflammatory response to lipopolysaccharide (LPS) in murine macrophages: inhibition of LPS binding to the cell surface.Lipopolysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharide-binding protein and phospholipid transfer protein.Lipopolysaccharide (LPS)-binding proteins BPI and LBP form different types of complexes with LPS.A novel flow cytometric assay to quantify soluble CD14 concentration in human serum.Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14.
P2860
Q24298291-A9882231-B94C-43C4-B478-F47A9F0FA5AEQ24514488-9CC48FF9-7195-4750-9862-E0647E33B40EQ24670236-5698479A-0175-4A60-AA03-DBCAC726FEC8Q24675633-C0A599A8-E786-4808-AEAD-AFBBF6452861Q27675591-82341996-16F9-4877-A38E-9093BEF099DBQ28084790-2CA25E7E-1D3D-4947-B19E-11A9385A7060Q28142299-17129D72-83BF-4E73-ADDA-8A8167EFAEDCQ30466776-325A9CA8-D54D-429F-A162-A8114883BA37Q33737234-10EEEBDC-0649-4AC6-9397-0BE4817ACA05Q33753970-1187B006-68D4-48C8-A2C3-8D964317ABE0Q33844399-1ECFD492-9C4C-414D-953D-5FEB3FF5DC77Q34589977-C3839D46-7608-473B-BA33-4C2251170824Q35011910-516932D8-E66D-4EEF-AD38-A4930098BEBBQ35176262-3FD8B7D1-A018-46CA-8EF6-511B193653EEQ35241037-A58427A0-B274-4BB6-998F-AF5BEC1C313AQ35676127-1F39F7F3-96FB-46D1-A46A-C3D4B4DB24DCQ35917056-992B5D52-C90F-4DC1-AD12-1582C08A92E9Q36500713-D82DAEC2-2E4F-4EA0-BC11-9DED4C2F2E14Q36746122-49D8B285-3EF5-4CCB-B68E-C2C19D006560Q37388139-67AA1721-704B-402C-B734-FF817837FC95Q39301377-38ABA406-27BA-4C1F-A98F-32B5B406FFF5Q39472979-590FDA06-57FA-4C70-9516-B4C3C1E32234Q39476293-8A5043CF-DF4D-4149-BCC1-01393F2F3A07Q39517945-ED3DAB08-0041-4BEA-A0CC-1F5E84B0A69EQ39537763-B320A1FA-02DD-431A-BF8D-507997D92F09Q39932936-50A91599-5DE3-44AD-AAEC-582A7DA01C18Q40040731-66C8A73F-998B-4E17-A6F7-6D97F6EB2B9BQ40384654-8D773ECD-598A-4F5A-8C94-7115897FD5B8Q40570201-1D6232AB-579F-457F-8AC7-FD20D9FF4B6DQ40654517-6E39D632-A8A6-4AF5-B552-F4636AE59FC0Q40813373-5C573BE1-193C-4F0F-92AF-FDA8F8CC81AEQ40858825-E0B5F2AA-C5F3-41F4-A4C2-00FC93EB24C7Q40937161-E6259EAC-3154-4BF2-BB83-40675E8CBC78Q41009891-C1544886-FFFA-440C-8B18-2D4565B90A04Q41065396-5F22CF81-3ACF-4AE2-BF68-BC58372FAE3DQ41844963-FD265132-389E-4225-BC69-C0557E9A69C4Q42727368-D47BF45A-12C9-41E8-944E-A2801FDF92EFQ43536172-BE46B5AB-D695-4E69-AC51-8534C50E62F9Q43759363-43771BCF-BA44-466B-96B3-5E184ABFFB7FQ44021134-7DABD618-5F68-45DF-A1CB-5AC6B6BEFA51
P2860
Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids.
@en
Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids.
@nl
type
label
Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids.
@en
Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids.
@nl
prefLabel
Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids.
@en
Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids.
@nl
P2093
P2860
P356
P1476
Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids.
@en
P2093
P2860
P304
P356
10.1172/JCI119160
P407
P577
1997-01-01T00:00:00Z